CTKB vs FDX · rev $92.3M vs P/E 18, rev $94.72B
Cytek Biosciences Inc (CTKB) versus FedEx Corporation (FDX) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
CTKB currently screens at market cap $421.8M. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Not investment advice. Open the CTKB and FDX stock pages for the full models.
Not investment advice.